Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. intergroup/RTOG 9704 phase III trial

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1319-1326

  Regine, William F ^a   Winter, Kathryn A ^b   Abrams, Ross ^c   Safran, Howard ^d   Hoffman, John P ^e   Konski, Andre ^f   Benson, Al B ^g   MacDonald, John S ^h   Rich, Tyvin A ⁱ   Willett, Christopher G ^j  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Therapy Group Statistical Center   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d MIRIAM HOSPITAL   (United States)

^e FOX CHASE CANCER CENTER   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h GI Oncology   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955841030     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1630-6     Document Type: Article

References (24)

1. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized trial JAMA. 297 267 277 17227978 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D (Pubitemid 46143304)
2. Neuhaus P, Riess H, Post S, et al. CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). J Clin Oncol. 2008;26(suppl LBA4504).
3. Neoptolemos J, Buchler M, Stocken DD, et al. ESPAC-3(v2): a multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folonic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol. 2009;27(suppl 18).
4. WF Regine K Winter RA Abrams, et al. 2008 Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA. 299 1019 1026 18319412 10.1001/jama.299.9.1019 1:CAS:528:DC%2BD1cXjtVSltL0%3D (Pubitemid 351347058)
5. SS Nicecki MG Sarr TV Colby, et al. 1995 Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 59 66 10.1097/00000658-199501000-00007
6. RJ Pirokowski SW Believernicht W Lawrence Jr, et al. 1982 Pancreatic and periampullary carcinoma: experience with 200 patients over a 12-year period Am J Surg. 143 189 193 10.1016/0002-9610(82)90064-2 (Pubitemid 12154586)
7. B Gudjonsson 1987 Cancer of the pancreas: 50 years of surgery Cancer. 60 2284 2303 3326653 10.1002/1097-0142(19871101)60:9<2284::AID- CNCR2820600930>3.0.CO;2-V 1:STN:280:DyaL1c7ltVKrtA%3D%3D (Pubitemid 17153498)
8. J Tepper G Nardi H Suit 1976 Carcinoma of the pancreas. Review of MGH experience from 1963-1973. Analysis of surgical failure and its implications for radiation therapy Cancer 37 1519 1524 1260670 10.1002/1097-0142(197603)37: 3<1519::AID-CNCR2820370340>3.0.CO;2-O 1:STN:280:DyaE287mt12juw%3D%3D
9. JF Griffin SR Smalley W Jewell, et al. 1990 Patterns of failure after curative resection of pancreatic carcinoma Cancer. 66 56 61 2354408 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6 1:STN:280:DyaK3c3otlyhtg%3D%3D (Pubitemid 20197085)
10. MH Kalser SS Ellenberg 1985 Pancreatic cancer Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 120 899 903 1:STN:280:DyaL2M3ltFSnsQ%3D%3D
11. JH Klinkenbijl J Jeekel T Sahmoud, et al. 1999 Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg. 230 776 782 10615932 10.1097/00000658-199912000- 00006 1:STN:280:DC%2BD3c%2FotFKkug%3D%3D (Pubitemid 30191812)
12. MM Corsini RC Miller MG Haddock, et al. 2008 Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005) J Clin Oncol. 26 3511 3516 18640932 10.1200/JCO.2007.15.8782
13. JM Herman MJ Schwartz CC Hsu, et al. 2008 Analysis of fluorouracil based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large prospectively collected database at the Johns Hopkins Hospital J Clin Oncol. 26 3503 3510 18640931 10.1200/JCO.2007.15.8469
14. ID Fleming, JS Cooper, DE Henson, et al. (1997) Exocrine pancreas. In: American Joint Committee on Cancer manual for staging of cancer. 5th ed. Philadelphia, PA: Lippincott-Raven, p. 122-3.
15. Regine WF. Postoperative adjuvant therapy: past, present, and future trial development. In: Evans DB, Pisters PWT, Abbruzzese JL, eds. Pancreatic cancer. New York: Springer; 2006. p. 235-42.
16. M Zelen 1974 The randomization and stratification of patients to clinical trials J Chronic Dis. 27 365 375 4612056 10.1016/0021-9681(74)90015-0 1:STN:280:DyaE2M%2FmtVKnug%3D%3D
17. RC Montgomery JP Hoffman LB Riley, et al. 1958 Prediction of recurrence and survival by post-resection CA19-9 values in patients with adenocarcinoma of the pancreas Ann Surg Oncol. 4 551 556 10.1007/BF02305535
18. EL Kaplan P Meier 1958 Nonparameteric estimation from incomplete observations J Am Stat Assoc 53 282 457 481 10.2307/2281868
19. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother. 50 163 170 1:STN:280:DyaF287ht1Wgug%3D%3D Rep
20. DR Cox 1972 Regression models and life tables J Royal Stat Soc Ser B. 34 187 229
21. CJ Yeo RA Abrams LB Grochow, et al. 1997 Pancreaticduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg. 225 621 636 9193189 10.1097/00000658-199705000-00018 1:STN:280:DyaK2szjs1Cgug%3D%3D (Pubitemid 28079110)
22. A Benson 2007 Adjuvant therapy for pancreatic cancer JAMA. 297 311 313 17227984 10.1001/jama.297.3.311 1:CAS:528:DC%2BD2sXotVClsQ%3D%3D (Pubitemid 46143311)
23. JP Neoptolemos DD Stocken H Friess, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med. 350 1200 1210 15028824 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D (Pubitemid 38339364)
24. MJ Moore D Goldstin Hamm, et al. 2007 Erlotinib Plus Gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol. 25 1960 1966 17452677 10.1200/JCO.2006.07.9525 1:CAS:528: DC%2BD2sXmvVWmsr0%3D (Pubitemid 46972777)